Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31364730 | 1.00 | MEN1 (0.43) | MEN1KMT2ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL31364717 | 0.90 | MEN1 (0.42) | MEN1KMT2ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL31364723 | 0.88 | MEN1 (0.41) | MEN1KMT2ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL31364712 | 0.88 | MEN1 (0.41) | MEN1KMT2ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL31364741 | 0.88 | MEN1 (0.41) | MEN1KMT2ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL31364707 | 0.88 | MEN1 (0.40) | MEN1KMT2ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL31364696 | 0.88 | MEN1 (0.41) | MEN1KMT2ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL31364735 | 0.88 | MEN1 (0.43) | MEN1KMT2ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL31364736 | 0.88 | MEN1 (0.46) | MEN1KMT2ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL31364754 | 0.87 | MEN1 (0.46) | MEN1KMT2ATHRBALOX15SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122029157-A | Bilobalide derivatives for the treatment of neurological diseases and cancers | 香港中文大学 | 2026-05-12 | — | — | CN | disclosed |
| WO-2025031304-A1 | BILOBALIDE DERIVATIVE COMPOUNDS FOR TREATING NEUROLOGICAL DISEASES AND CANCERS | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2025-02-13 | — | — | WO | disclosed |